Immune intervention in type 1 diabetes
- 1 June 2011
- journal article
- review article
- Published by Elsevier in Seminars in Immunology
- Vol. 23 (3) , 214-219
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding ratDiabetologia, 2010
- Diabetogenic T cells recognize insulin bound to IAg7in an unexpected, weakly binding registerProceedings of the National Academy of Sciences, 2010
- Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 yearsClinical Immunology, 2009
- C-Peptide Levels and Insulin Independence Following Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes MellitusJAMA, 2009
- Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic miceProceedings of the National Academy of Sciences, 2008
- Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety studyClinical and Experimental Immunology, 2008
- GAD Treatment and Insulin Secretion in Recent-Onset Type 1 DiabetesNew England Journal of Medicine, 2008
- Curative and β cell regenerative effects of α1-antitrypsin treatment in autoimmune diabetic NOD miceProceedings of the National Academy of Sciences, 2008
- The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetesProceedings of the National Academy of Sciences, 2007
- CD3-specific antibodies: a portal to the treatment of autoimmunityNature Reviews Immunology, 2007